MyCycle will disrupt the at-home fertility ‘rapid-test’ space with a brand
that speaks to a new generation of consumers, providing men and women
with instant information and a new product. We have secured a worldwide patent for a urine-based, at-home Ovarian Reserve (FSH) screening test that women can use to understand their reproductive potential. Priced at only ~$35, this information comes at a fraction of the cost and effort of alternatives.